Literature DB >> 9150354

A patient with myeloma who still has pure red cell aplasia despite the most intensive immune modulation.

J Orchard1, H Myint, T J Hamblin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9150354     DOI： 10.1016/s0145-2126(97)00028-3

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  5 in total

1.  Treatment of pure red cell aplasia associated with multiple myeloma with biclonal gammopathy using cyclosporine A: a case report.

Authors:  Yali Lv; Wenbin Qian
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Monoclonal gammopathy-associated pure red cell aplasia.

Authors:  Neha Korde; Yong Zhang; Kelsey Loeliger; Andrea Poon; Olga Simakova; Adriana Zingone; Rene Costello; Richard Childs; Pierre Noel; Samuel Silver; Mary Kwok; Clifton Mo; Neal Young; Ola Landgren; Elaine Sloand; Irina Maric
Journal:  Br J Haematol       Date:  2016-03-21       Impact factor: 6.998

3.  Clinical Resolution of Red Cell Aplasia Associated del 17p Multiple Myeloma, When Treated With Bortezomib and Dexamethasone.

Authors:  Abdullah Ladha; Yelena Fudym; Teresa C Gentile
Journal:  J Hematol (Brossard)       Date:  2017-01-10

4.  Rational management approach to pure red cell aplasia.

Authors:  Suresh Kumar Balasubramanian; Meena Sadaps; Swapna Thota; Mai Aly; Bartlomiej P Przychodzen; Cassandra M Hirsch; Valeria Visconte; Tomas Radivoyevitch; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2017-12-07       Impact factor: 9.941

5.  Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide.

Authors:  Tomoki Ito; Aya Nakaya; Shinya Fujita; Atsushi Satake; Takahisa Nakanishi; Yoshiko Azuma; Yukie Tsubokura; Akiko Konishi; Masaaki Hotta; Hideaki Yoshimura; Kazuyoshi Ishii; Shosaku Nomura
Journal:  Leuk Res Rep       Date:  2018-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.